These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 19331864)

  • 1. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
    Yang Y; Wang J; Zhang X; Lu W; Zhang Q
    J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
    Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
    Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation.
    Chen L; Sha X; Jiang X; Chen Y; Ren Q; Fang X
    Int J Nanomedicine; 2013; 8():73-84. PubMed ID: 23319859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
    Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
    Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines.
    Gao L; Wang X; Ma J; Hao D; Wei P; Zhou L; Liu G
    Colloids Surf B Biointerfaces; 2016 Apr; 140():307-316. PubMed ID: 26764117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
    Lee E; Kim H; Lee IH; Jon S
    J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
    Tong SW; Xiang B; Dong DW; Qi XR
    Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer.
    Chang CE; Hsieh CM; Chen LC; Su CY; Liu DZ; Jhan HJ; Ho HO; Sheu MT
    Drug Deliv; 2018 Nov; 25(1):632-643. PubMed ID: 29463123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel.
    Gao Y; Ren F; Ding B; Sun N; Liu X; Ding X; Gao S
    J Drug Target; 2011 Aug; 19(7):516-27. PubMed ID: 20883085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight methylcellulose-based thermo-reversible gel/pluronic micelle combination system for local and sustained docetaxel delivery.
    Kim JK; Won YW; Lim KS; Kim YH
    Pharm Res; 2012 Feb; 29(2):525-34. PubMed ID: 21904934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery.
    Shi J; Zhang J; Shen Y; Tang L; Zhao J; Tu J; Tian Y; Feng Y
    Drug Deliv; 2015 Feb; 22(2):168-81. PubMed ID: 24215124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels.
    Zahedi P; Stewart J; De Souza R; Piquette-Miller M; Allen C
    J Control Release; 2012 Mar; 158(3):379-85. PubMed ID: 22154933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role?
    Ostacolo L; Marra M; Ungaro F; Zappavigna S; Maglio G; Quaglia F; Abbruzzese A; Caraglia M
    J Control Release; 2010 Dec; 148(2):255-63. PubMed ID: 20816710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-phospholipid blend for sustained and localized delivery of docetaxel to the peritoneal cavity.
    Zahedi P; De Souza R; Piquette-Miller M; Allen C
    Int J Pharm; 2009 Jul; 377(1-2):76-84. PubMed ID: 19442712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
    Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
    J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
    Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q
    J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysialic acid and pluronic F127 mixed polymeric micelles of docetaxel as new approach for enhanced antitumor efficacy.
    Zhang T; Zhou S; Liu Y; Luo X; Di D; Song Y; Liu X; Deng Y
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1827-1835. PubMed ID: 28678638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N,N,N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor.
    Turabee MH; Jeong TH; Ramalingam P; Kang JH; Ko YT
    Carbohydr Polym; 2019 Jan; 203():302-309. PubMed ID: 30318217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.
    Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S
    J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.